Laboratory studies further underscore its potential for improving gut health, spinal cord injury recovery, chronic pain management, and cognitive function, suggesting possible future clinical applications
Certificate of Analysis and batch specific details should be reviewed prior to use in any research setting
KPV Research Foundation Studies published in journals including Gut, Inflammatory Bowel Diseases, and the Journal of Immunology have shown that KPV reduces inflammation in models of colitis, with research by Kannengiesser and colleagues demonstrating that oral nanoparticle delivery of KPV decreases inflammation in dextran sulfate sodium (DSS)-induced colitis models
B12 injections may help lower levels of homocysteine, an amino acid that, when elevated, can be a risk factor for heart disease and stroke
El BPC-157 es un pptido de investigacin no aprobado como medicamento por la AEMPS ni por la EMA para uso en humanos